Stockscreener 앱 받기
3.43
1.72%
-0.06
전일 마감가:
$3.49
열려 있는:
$3.3
하루 거래량:
4,768
Relative Volume:
0.68
시가총액:
$23.03M
수익:
-
순이익/손실:
$-23.87M
주가수익비율:
-0.0945
EPS:
-36.3
순현금흐름:
$-47.63M
1주 성능:
+0.29%
1개월 성능:
+3.94%
6개월 성능:
-27.11%
1년 성능:
-16.55%
1일 변동 폭
$3.30
$3.49
1주일 범위
$3.225
$3.62
52주 변동 폭
$2.95
$9.20
폴리피드 Stock (PYPD) Company Profile
PYPD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PYPD | 3.43 | 23.03M | 0 | -23.87M | -47.63M | -36.30 |
| VRTX | 448.70 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.23 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 597.88 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.48 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.11 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
폴리피드 Stock (PYPD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-14 | 개시 | JMP Securities | Mkt Outperform |
| 2021-07-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-24 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-10 | 개시 | Alliance Global Partners | Buy |
| 2020-07-21 | 개시 | BMO Capital Markets | Outperform |
| 2020-07-21 | 개시 | Barclays | Overweight |
| 2020-07-21 | 개시 | Raymond James | Outperform |
모두보기
폴리피드 주식(PYPD)의 최신 뉴스
PolyPid Ltd. (NASDAQ:PYPD) Q3 2024 Earnings Call Transcript - Insider Monkey
PolyPid Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
PolyPid Ltd (PYPD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
PolyPid Reports Q3 Results Amid SHIELD II Trial Progress - TipRanks
PolyPid Announces SHIELD II Trial Progress and Financials - TipRanks
PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewswire
PolyPid's SHIELD II Trial Hits Key Milestone as R&D Costs Rise 58% in Q3 | PYPD Stock News - StockTitan
PolyPid (PYPD) to Release Earnings on Wednesday - Defense World
PolyPid Announces $8.25 Million Share Sale Plan - TipRanks
PYPDPolyPid Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
PolyPid to Participate in the Craig-Hallum 15th Annual Alpha Select Conference - StockTitan
Craig-Hallum Initiates Coverage of PolyPid (PYPD) with Buy Recommendation - MSN
PolyPid shares rise on strong Phase 3 prospects, gets buy rating - Investing.com Canada
PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024 - GlobeNewswire
Will PolyPid Wield The SHIELD? - RTTNews
Rosalind Advisors, Inc. Reduces Stake in PolyPid Ltd - GuruFocus.com
PolyPid Announces Publication in International Journal of - GlobeNewswire
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery - StockTitan
PolyPid retains stock target, buy rating on positive trial enrollment update By Investing.com - Investing.com South Africa
PolyPid retains stock target, buy rating on positive trial enrollment update - Investing.com India
PolyPid completes enrollment for phase 3 trial - Investing.com
PolyPid Nears Completion of Key Phase 3 Trial - TipRanks
PolyPid Announces Last Patient In for Planned Unblinded - GlobeNewswire
PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections - StockTitan
PolyPid to Participate in Three Upcoming Fall Investor Conferences - GlobeNewswire
Equities Analysts Offer Predictions for PolyPid Ltd.’s Q3 2024 Earnings (NASDAQ:PYPD) - Defense World
HC Wainwright Reiterates “Buy” Rating for PolyPid (NASDAQ:PYPD) - Defense World
PolyPid Ltd. (NASDAQ:PYPD) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: PolyPid reports a net loss of $6.3 million in the second-quarter of 2024 - Investing.com
PolyPid Reports Growth in Mid-Year Assets - TipRanks
PolyPid Advances SHIELD II Trial with Solid Financing - TipRanks
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results - GlobeNewswire
Analyzing Silk Road Medical (NASDAQ:SILK) & PolyPid (NASDAQ:PYPD) - Defense World
PolyPid (PYPD) Scheduled to Post Earnings on Wednesday - Defense World
PolyPid secures $14 million in private placement - Investing.com
PolyPid secures $14 million in private placement By Investing.com - Investing.com UK
PolyPid Secures Funding, Extends Runway for D-PLEX100 Trial - TipRanks
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds - StockTitan
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - GlobeNewswire
PolyPid stock hits 52-week low at $3.35 amid market challenges - Investing.com
PolyPid (NASDAQ:PYPD) Trading 1.7% Higher - Defense World
폴리피드 (PYPD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):